pocketful logo
Sarda Proteins Ltd logo

Sarda Proteins Ltd

NSE: BSE: 519242

₹84.48

(0%)

Sun, 05 Apr 2026, 04:23 pm

Sarda Proteins EV/EBITDA Ratio

Particulars20082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio64.620014.75001.94000054.43020.940478.134210
Price to book ratio0.700.630.460.480.530.550.460.330.320.410.600.850.872.704.243.919.05
Price to sales ratio0.080.090.050.040.090.490.230.420.120.140.160.330.160.601.727.160.89
Price to cash flow ratio01.616.21652.98000001.64056.5557.2233.97000
Enterprise value24.71M13.93M7.04M8.84M9.97M14.42M2.82M11.79M6.97M2.77M10.72M16.89M16.71M61.12M97.84M91.65M214.97M
Enterprise value to EBITDA ratio22.48000000000017.21022.59001100
Debt to equity ratio0.2600.010.020.010.110.060.250.0800000000
Return on equity %0-6.19-8.113.19-12.24-4.2319.02-5.23-5.49-15.21-6.341.65-0.9713.77-1.390.820.21

Sarda Proteins Ltd Enterprise Value to EBITDA Ratio

The Sarda Proteins Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Sarda Proteins Ltd's valuation, profitability, and overall financial performance. Tracking the Sarda Proteins Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Sarda Proteins Ltd (NSE: , BSE: 519242) is currently trading at ₹84.48, with a market capitalization of ₹145.8M. As a leading company in the Process industries sector and Agricultural commodities/Milling industry, monitoring the Sarda Proteins Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Sarda Proteins Ltd Enterprise Value to EBITDA Ratio Current Value

The current Sarda Proteins Ltd Enterprise Value to EBITDA Ratio stands at 1100.

The latest Sarda Proteins Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Sarda Proteins Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Sarda Proteins Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

  • 2024: 1100
  • 2023: 0
  • 2022: 0
  • 2021: 22.59
  • 2020: 0

The recent rise in Sarda Proteins Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Sarda Proteins Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Sarda Proteins Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Sarda Proteins Ltd.

Sarda Proteins Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Sarda Proteins Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sarda Proteins Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Sarda Proteins Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800